EPAD - European Prevention of Alzheimer's Dementia

European Prevention of Alzheimer's Dementia

- Newsletter January 2016 -

Serge Van der Geyten - EPAD Coordinator



The European Prevention of Alzheimer's Dementia (EPAD) project kicked-off in Paris a little over a year ago, and what a year it has been. We started as 35 partners and as the year progressed we became more than a partnership, paraphrasing Craig Ritchie, we became “the EPAD family”, all working together in the fight against Alzheimer’s dementia. In the mean-time EPAD welcomed a new partner, Aridhia, and it looks like we might be extending the family with another partner in 2017 (more on this coming soon).

Today we are celebrating EPAD’s first anniversary with the maiden issue of the EPAD Newsletter. This electronic newsletter will be published quarterly and be accessible via the EPAD website (www.ep-ad.org) and inform the Alzheimer community on EPAD’s main achievements, upcoming events as well as allow you to meet the scientists who make it all happen.

In this first issue, an overview of the project's main achievements of 2015 is presented. You can also find out more about 2 of the EPAD collaborators, Judi Syson and Lennert Steukers.

We hope you enjoy this first issue of the EPAD newsletter and look forward on working with all of you on EPAD in the year ahead. 

Serge Van der Geyten

EPAD Coordinator

15 January 2016: EPAD turns one today!

2015 Highlights

15 January 2016: EPAD turns one today!

January 15th marked the first anniversary of the official launch of the European Prevention of Alzheimer’s Dementia (EPAD) Initiative in Paris. To celebrate turning one, we look back at some of our key achievements of the past 12 months. March On 19 March, the Innovative Medicines Initiative (IMI) launched its Alzheimer’s Disease Research Platform, with EPAD as one of its …

Read more.

Snapshot EPAD paper - The Lancet Psychiatry

The story behind the picture

First EPAD publication is out in The Lancet Psychiatry!

Development of interventions for the secondary prevention of Alzheimer's dementia: the European Prevention of Alzheimer's Dementia (EPAD) project Summary Alzheimer's dementia affects more than 40 million people worldwide with substantial increases in prevalence anticipated. Interventions that either modify risk or reduce the development of early disease could delay the onset of dementia or reduce the rate of cognitive and functional …

Read more.


Meet the EPAD team

Lennert Steukers

Interview with Lennert Steukers

What is your current role in EPAD? I’m currently working full time as project manager for Janssen on the IMI-EPAD project. My main role, as member of the EPAD Project Management office and WP5, is to provide overall management to the project including supporting the coordinator in liaising with IMI, work plan & schedule control, stakeholder management, team communication, supporting …

Read more.

Judi Syson

Interview with Judi Syson

What is your current role in EPAD? I’m the International Coordinator for WP4 (EPAD cohort and proof of concept studies) based at the University of Edinburgh with Professor Craig Ritchie. I also represent WP4 on the Clinical Development Group as the Operational Manager. The roles involve working with the Trial Delivery Centres to get them certified as EPAD centres, set …

Read more.

EPAD design

EPAD presents @

• 14th International Athens/Springfield Symposium on Advances in Alzheimer Therapy - Symposium: An Alzheimer’s disease odyssey: Navigating the road towards 2025 - March 9th 2016 by José Luis Molinuevo - Symposium is supported by Roche and chaired by George Vradenburg.


Quarterly Quote

None of us wants to be reminded that dementia is random, relentless, and frighteningly common.
 - Laurie Graham -